Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC, Bhatia S, Amin A, Pavlick AC, Betts KA, Du EX, Poretta T, Shelley K, Srinivasan S, Sakkal LA, Palaia J, Lobo M, Pe Benito M, Linton JA, Chen Y, Xu C, Yin L, Sundar M, Weber J. Moser JC, et al. Among authors: du ex. Cancer Immunol Immunother. 2024 May 7;73(7):116. doi: 10.1007/s00262-024-03697-3. Cancer Immunol Immunother. 2024. PMID: 38713408 Clinical Trial.
MAM 2024: Malaria in a changing world.
Longley RJ, Malinga J, Hesping E, Sutanto E, DonVito SM, Kucharski M, Oyong DA, Verhoef JMJ, Du E, Villasis E, Mwikali K. Longley RJ, et al. Among authors: du e. Trends Parasitol. 2024 May;40(5):355-361. doi: 10.1016/j.pt.2024.03.007. Epub 2024 Apr 12. Trends Parasitol. 2024. PMID: 38609740 No abstract available.
Next generation microfluidics: fulfilling the promise of lab-on-a-chip technologies.
Gurkan UA, Wood DK, Carranza D, Herbertson LH, Diamond SL, Du E, Guha S, Di Paola J, Hines PC, Papautsky I, Shevkoplyas SS, Sniadecki NJ, Pamula VK, Sundd P, Rizwan A, Qasba P, Lam WA. Gurkan UA, et al. Among authors: du e. Lab Chip. 2024 Mar 26;24(7):1867-1874. doi: 10.1039/d3lc00796k. Lab Chip. 2024. PMID: 38487919 Free PMC article. Review.
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
Rimel BJ, Chase DM, Perhanidis J, Ghazarian AA, Du EX, Wang T, Song J, Golembesky AK, Hurteau JA, Kalilani L, Salani R, Monk BJ. Rimel BJ, et al. Among authors: du ex. Gynecol Oncol Rep. 2024 Feb 7;51:101332. doi: 10.1016/j.gore.2024.101332. eCollection 2024 Feb. Gynecol Oncol Rep. 2024. PMID: 38362364 Free PMC article.
454 results